María Luisa Martínez Ginés

Multiple Sclerosis

Clinical research is centered on multiple sclerosis, with attention to brain network activity and functional changes associated with the disease.

  • Central nervous system involvement
  • Functional connectivity
  • Default mode network

The sponsor’s research interest includes the neurological impact of treatment in multiple sclerosis and the study of disease-related alterations in cognitive and functional brain organization.

Neuroimaging

Research activity includes neuroimaging approaches used to assess brain network behavior in patients receiving treatment for multiple sclerosis.

  • Brain connectivity
  • Resting-state network activity
  • Functional brain mapping

The focus extends to identifying patterns of default mode network activation and their relationship to neurological status in a clinical setting.

Neurological Treatment Response

The sponsor is involved in research examining how treatment influences neurological function in multiple sclerosis, with interest in changes linked to cladribine therapy.

  • Therapeutic response
  • Brain function changes
  • Neurofunctional assessment

This area reflects a clinical interest in how disease-modifying treatment relates to measurable changes in brain activity patterns.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Cladribine for Patients with Multiple Sclerosis to Evaluate Brain Network Changes

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain